Profile | GDS5420 / 232423_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 238.06 | 55 |
GSM1296119 | B_lesional_pre-dose | 118.92 | 43 |
GSM1296076 | C_lesional_pre-dose | 39.43 | 27 |
GSM1296092 | D_lesional_pre-dose | 56.04 | 35 |
GSM1296103 | E_lesional_pre-dose | 412.13 | 64 |
GSM1296078 | F_lesional_pre-dose | 110.93 | 44 |
GSM1296107 | G_lesional_pre-dose | 192.33 | 51 |
GSM1296109 | H_lesional_pre-dose | 404.07 | 63 |
GSM1296080 | I_lesional_pre-dose | 185 | 52 |
GSM1296090 | J_lesional_pre-dose | 55.48 | 34 |
GSM1296074 | K_lesional_pre-dose | 12.31 | 13 |
GSM1296111 | L_lesional_pre-dose | 131.82 | 44 |
GSM1296099 | M_lesional_pre-dose | 173.39 | 50 |
GSM1296086 | O_lesional_pre-dose | 52.62 | 33 |
GSM1296117 | P_lesional_pre-dose | 41.49 | 25 |
GSM1296113 | Q_lesional_pre-dose | 149.66 | 45 |
GSM1296096 | R_lesional_pre-dose | 157.35 | 49 |
GSM1296105 | S_lesional_pre-dose | 144.44 | 46 |
GSM1296098 | T_lesional_pre-dose | 35.36 | 23 |
GSM1296101 | U_lesional_pre-dose | 197.67 | 52 |
GSM1296121 | V_lesional_pre-dose | 191.73 | 51 |
GSM1296088 | W_lesional_pre-dose | 122.34 | 45 |
GSM1296082 | X_lesional_pre-dose | 86.34 | 41 |
GSM1296115 | Y_lesional_pre-dose | 181.01 | 50 |
GSM1296084 | Z_lesional_pre-dose | 58.98 | 33 |
GSM1296072 | B_lesional_day8 | 135.07 | 45 |
GSM1296069 | L_lesional_day8 | 150.6 | 45 |
GSM1296071 | P_lesional_day8 | 32.61 | 21 |
GSM1296070 | Y_lesional_day8 | 109.56 | 40 |
GSM1296073 | V_lesional_day8 | 158.58 | 49 |
GSM1296034 | A_lesional_day15 | 345.55 | 60 |
GSM1296041 | G_lesional_day15 | 156.96 | 48 |
GSM1296035 | R_lesional_day15 | 190.44 | 52 |
GSM1296038 | U_lesional_day15 | 135.95 | 46 |
GSM1296047 | B_lesional_day15 | 162.47 | 48 |
GSM1296039 | E_lesional_day15 | 206.26 | 53 |
GSM1296042 | H_lesional_day15 | 241.06 | 54 |
GSM1296043 | L_lesional_day15 | 163.03 | 47 |
GSM1296037 | M_lesional_day15 | 110.22 | 42 |
GSM1296046 | P_lesional_day15 | 33.69 | 21 |
GSM1296044 | Q_lesional_day15 | 181.11 | 49 |
GSM1296045 | Y_lesional_day15 | 126.86 | 42 |
GSM1296025 | C_lesional_day15 | 0.21 | 0 |
GSM1296033 | D_lesional_day15 | 28.73 | 23 |
GSM1296027 | I_lesional_day15 | 117.25 | 46 |
GSM1296032 | J_lesional_day15 | 52.24 | 32 |
GSM1296024 | K_lesional_day15 | ||
GSM1296031 | W_lesional_day15 | 236.77 | 54 |
GSM1296028 | X_lesional_day15 | 96.18 | 41 |
GSM1296029 | Z_lesional_day15 | 51.29 | 32 |
GSM1296026 | F_lesional_day15 | ||
GSM1296030 | O_lesional_day15 | 26.47 | 25 |
GSM1296040 | S_lesional_day15 | 173.11 | 50 |
GSM1296036 | T_lesional_day15 | 13.32 | 11 |
GSM1296048 | V_lesional_day15 | 136.32 | 45 |
GSM1296059 | A_lesional_day43 | 303.33 | 59 |
GSM1296066 | G_lesional_day43 | 243.29 | 55 |
GSM1296060 | R_lesional_day43 | 173.82 | 50 |
GSM1296063 | U_lesional_day43 | 124.47 | 44 |
GSM1296064 | E_lesional_day43 | 131.67 | 46 |
GSM1296067 | H_lesional_day43 | 276.85 | 56 |
GSM1296062 | M_lesional_day43 | 208.29 | 53 |
GSM1296068 | Q_lesional_day43 | 231.78 | 53 |
GSM1296050 | C_lesional_day43 | 8.19 | 7 |
GSM1296057 | D_lesional_day43 | 53.14 | 33 |
GSM1296052 | I_lesional_day43 | 106.5 | 44 |
GSM1296054 | J_lesional_day43 | 23.99 | 20 |
GSM1296049 | K_lesional_day43 | 10.54 | 10 |
GSM1296055 | W_lesional_day43 | 175.14 | 49 |
GSM1296053 | X_lesional_day43 | 258.9 | 56 |
GSM1296058 | Z_lesional_day43 | 19.13 | 19 |
GSM1296051 | F_lesional_day43 | 113.17 | 44 |
GSM1296056 | O_lesional_day43 | 38.57 | 29 |
GSM1296065 | S_lesional_day43 | 150.35 | 47 |
GSM1296061 | T_lesional_day43 | 50.67 | 30 |
GSM1296095 | A_non-lesional_pre-dose | 108.6 | 43 |
GSM1296120 | B_non-lesional_pre-dose | 149.52 | 46 |
GSM1296077 | C_non-lesional_pre-dose | 11.28 | 11 |
GSM1296093 | D_non-lesional_pre-dose | 59.67 | 33 |
GSM1296104 | E_non-lesional_pre-dose | 274.51 | 58 |
GSM1296079 | F_non-lesional_pre-dose | 19.84 | 17 |
GSM1296108 | G_non-lesional_pre-dose | 148.45 | 46 |
GSM1296110 | H_non-lesional_pre-dose | 280.5 | 56 |
GSM1296081 | I_non-lesional_pre-dose | 205.94 | 54 |
GSM1296091 | J_non-lesional_pre-dose | 63.57 | 35 |
GSM1296075 | K_non-lesional_pre-dose | 7.01 | 6 |
GSM1296112 | L_non-lesional_pre-dose | 203.23 | 50 |
GSM1296100 | M_non-lesional_pre-dose | 381.64 | 62 |
GSM1296087 | O_non-lesional_pre-dose | 39.97 | 30 |
GSM1296118 | P_non-lesional_pre-dose | 60.91 | 30 |
GSM1296114 | Q_non-lesional_pre-dose | 172.2 | 48 |
GSM1296097 | R_non-lesional_pre-dose | 160.4 | 49 |
GSM1296106 | S_non-lesional_pre-dose | 340.26 | 60 |
GSM1296102 | U_non-lesional_pre-dose | 158.1 | 47 |
GSM1296122 | V_non-lesional_pre-dose | 65.66 | 32 |
GSM1296089 | W_non-lesional_pre-dose | 184.63 | 50 |
GSM1296083 | X_non-lesional_pre-dose | 120.97 | 44 |
GSM1296116 | Y_non-lesional_pre-dose | 197.95 | 50 |
GSM1296085 | Z_non-lesional_pre-dose | 90.25 | 40 |